SCHEMBL4860186

SCHEMBL4860186

C=CC(=O)OC12CC3CC(CC(OCSC)(C3)C1)C2

nearest known ligand 0.36

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.31
ALDH1A1 P00352 1/20 0.31
KMT2A Q03164 1/20 0.31
GAA P10253 1/20 0.31
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12153604 0.86 GAA (0.33) MEN1ALDH1A1KMT2AGAATSHR
SCHEMBL822780 0.85 ALDH1A1 (0.36) MEN1ALDH1A1KMT2AGAATSHR
SCHEMBL12170586 0.84 MEN1 (0.33) MEN1ALDH1A1KMT2ATSHR
SCHEMBL13998864 0.83 MEN1 (0.33) MEN1ALDH1A1KMT2AGAA
SCHEMBL12190112 0.82 EPHX2 (0.35) GAA
SCHEMBL3451429 0.82 TSHR (0.39) MEN1ALDH1A1KMT2ATSHR
SCHEMBL29120543 0.81 GAA (0.33) ALDH1A1GAATSHR
SCHEMBL6560570 0.81 DPP4 (0.37) MEN1ALDH1A1KMT2ATSHR
SCHEMBL4864749 0.81 DPP8 (0.31) MEN1ALDH1A1KMT2A
SCHEMBL4864929 0.81 GAA (0.31) ALDH1A1GAATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7456311-B2 Adamantane derivative, process for producing the same, and photosensitive material for photoresist IDEMITSU KOSAN CO., LTD. (JP) 2008-11-25 US disclosed
US-20080009647-A1 Adamantane Derivative, Process for Producing the Same, and Photosensitive Material for Photoresist IDEMITSU KOSAN CO., LTD. (JP) 2008-01-10 US disclosed
EP-1803708-A1 ADAMANTANE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND PHOTOSENSITIVE MATERIAL FOR PHOTORESIST IDEMITSU KOSAN CO., LTD. (JP) 2007-07-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080009647-A1 Adamantane Derivative, Process for Producing the Same, and Photosensitive Material for Photoresist LSS, C1S, DHPS MEN1 1643/4885ALDH1A1 1544/4885KMT2A 2612/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.